These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28952140)

  • 1. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
    Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
    Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant concurrent chemoradiation therapy in patients with microscopic residual tumor after curative resection for extrahepatic cholangiocarcinoma.
    Lee J; Kang SH; Noh OK; Chun M; Oh YT; Kim BW; Kim SW
    Clin Transl Oncol; 2018 Aug; 20(8):1011-1017. PubMed ID: 29256155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
    Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
    Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant Chemotherapy and Radiation Therapy is Associated with Improved Survival for Patients with Extrahepatic Cholangiocarcinoma.
    Hoehn RS; Wima K; Ertel AE; Meier A; Ahmad SA; Shah SA; Abbott DE
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1133-9. PubMed ID: 25976862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
    Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
    Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
    Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
    Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
    Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium.
    Krasnick BA; Jin LX; Davidson JT; Sanford DE; Ethun CG; Pawlik TM; Poultsides GA; Tran T; Idrees K; Hawkins WG; Chapman WC; Doyle MBM; Weber SM; Strasberg SM; Salem A; Martin RCG; Isom CA; Scoggins C; Schmidt CR; Shen P; Beal E; Hatzaras I; Shenoy R; Maithel SK; Fields RC
    J Surg Oncol; 2018 Mar; 117(3):363-371. PubMed ID: 29284072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
    Kamarajah SK; Bednar F; Cho CS; Nathan H
    Cancer; 2021 Apr; 127(8):1266-1274. PubMed ID: 33320344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Survival in Surgically Resected Distal Cholangiocarcinoma Treated with Adjuvant Therapy: a Propensity Score Matched Analysis.
    Hester C; Nassour I; Adams-Huet B; Augustine M; Choti MA; Minter RM; Mansour JC; Polanco PM; Porembka MR; Wang SC; Yopp AC
    J Gastrointest Surg; 2018 Dec; 22(12):2080-2087. PubMed ID: 30030718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
    Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
    Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
    Vern-Gross TZ; Shivnani AT; Chen K; Lee CM; Tward JD; MacDonald OK; Crane CH; Talamonti MS; Munoz LL; Small W
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):189-98. PubMed ID: 20971573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy?
    Patel SH; Kooby DA; Staley CA; Sarmiento JM; Maithel SK
    HPB (Oxford); 2011 Sep; 13(9):605-11. PubMed ID: 21843260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholangiocarcinoma: clinical significance of tumor location along the extrahepatic bile duct.
    Alden ME; Waterman FM; Topham AK; Barbot DJ; Shapiro MJ; Mohiuddin M
    Radiology; 1995 Nov; 197(2):511-6. PubMed ID: 7480704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Therapy Is Associated With Improved Survival in Resected Perihilar Cholangiocarcinoma: A Propensity Matched Study.
    Nassour I; Mokdad AA; Porembka MR; Choti MA; Polanco PM; Mansour JC; Minter RM; Wang SC; Yopp AC
    Ann Surg Oncol; 2018 May; 25(5):1193-1201. PubMed ID: 29488187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of adjuvant (chemo)radiotherapy for resected extrahepatic cholangiocarcinoma: a meta-analysis.
    Shi XQ; Zhang JY; Tian H; Tang LN; Li AL
    J Zhejiang Univ Sci B; 2020 Jul; 21(7):549-559. PubMed ID: 32633109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma.
    Sur MD; In H; Sharpe SM; Baker MS; Weichselbaum RR; Talamonti MS; Posner MC
    Ann Surg Oncol; 2015 Jul; 22(7):2209-17. PubMed ID: 25476031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis.
    Ejaz A; Spolverato G; Kim Y; Squires MH; Poultsides G; Fields R; Bloomston M; Weber SM; Votanopoulos K; Worhunsky DJ; Swords D; Jin LX; Schmidt C; Acher AW; Saunders N; Cho CS; Herman JM; Maithel SK; Pawlik TM
    Ann Surg Oncol; 2014 Oct; 21(11):3412-21. PubMed ID: 24845728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy.
    Kelley ST; Bloomston M; Serafini F; Carey LC; Karl RC; Zervos E; Goldin S; Rosemurgy P; Rosemurgy AS
    Am Surg; 2004 Sep; 70(9):743-8; discussion 748-9. PubMed ID: 15481288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.